{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:58:48Z","timestamp":1793174328899,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21976008"],"award-info":[{"award-number":["21976008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1967216"],"award-info":[{"award-number":["U1967216"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["2252008"],"award-info":[{"award-number":["2252008"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["U1967216"],"award-info":[{"award-number":["U1967216"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejmech.2025.117443","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T04:17:02Z","timestamp":1740457022000},"page":"117443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Synthesis and in vitro evaluation of radioiodine labeled hypoxia-targeted drugs containing 2-nitroimidazole and benzenesulfonamide groups"],"prefix":"10.1016","volume":"289","author":[{"given":"Weiqi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0566-786X","authenticated-orcid":false,"given":"Taiwei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejmech.2025.117443_bib1","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/STROKEAHA.107.485938","article-title":"Applications of nitroimidazole in vivo hypoxia imaging in ischemic stroke","volume":"39","author":"Takasawa","year":"2008","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.ejmech.2025.117443_bib2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1248\/yakushi.18-00146","article-title":"Accumulation mechanism of 2-nitroimidazole-based hypoxia imaging probes revealed by imaging mass spectrometry","volume":"138","author":"Shimizu","year":"2018","journal-title":"Yakugaku Zasshi-J. Pharm. Soc. Jpn."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117443_bib3","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/jcm8081088","article-title":"The roles of hypoxia imaging using 18F-fluoromisonidazole positron emission tomography in glioma treatment","volume":"8","author":"Hirata","year":"2019","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117443_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s002590050365","article-title":"Introducing fluorine-18 fluoromisonidazole positron emission tomography for the localisation and quantification of pig liver hypoxia","volume":"26","author":"Piert","year":"1999","journal-title":"Eur. J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117443_bib5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11307-021-01580-6","article-title":"Evaluation of optimal post-injection timing of hypoxic imaging with 18F-fluoromisonidazole-PET\/CT","volume":"23","author":"Kawamura","year":"2021","journal-title":"Mol. Imag. Biol."},{"issue":"15","key":"10.1016\/j.ejmech.2025.117443_bib6","doi-asserted-by":"crossref","first-page":"13491","DOI":"10.1021\/acs.jmedchem.4c01420","article-title":"68Ga\/177Lu-labeled bivalent agents for targeting hypoxia and PSMA-binding in prostate cancer","volume":"67","author":"Luo","year":"2024","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117443_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cmmi.1649","article-title":"68Ga -HP-DO3A-nitroimidazole: a promising agent for PET detection of tumor hypoxia","volume":"10","author":"Wu","year":"2015","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.ejmech.2025.117443_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129773","article-title":"Preparation and bioevaluation of a novel 99mTc-labelled propylene amine oxime (PnAO) containing two 4-methyl-2-nitroimidazole groups as a promising tumor hypoxia imaging agent","volume":"106","author":"Li","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117443_bib9","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3390\/ph16091276","article-title":"Synthesis and evaluation of 99mTc-labelled 2-nitroimidazole derivatives with different linkers for tumour hypoxia imaging","volume":"16","author":"Ruan","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117443_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1039\/b313872k","article-title":"Radiohalogens for imaging and therapy","volume":"34","author":"Adam","year":"2005","journal-title":"Chem. Soc. Rev."},{"issue":"17","key":"10.1016\/j.ejmech.2025.117443_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127386","article-title":"Synthesis and bioevaluation of radioiodinated nitroimidazole hypoxia imaging agents by one-pot click reaction","volume":"30","author":"Yang","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"15","key":"10.1016\/j.ejmech.2025.117443_bib12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1359-6446(04)03163-0","article-title":"From magic bullets to designed multiple ligands","volume":"9","author":"Morphy","year":"2004","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117443_bib13","first-page":"60","article-title":"Pitfalls of F-18 FMISO PET in evaluation of tumor hypoxia after radiation therapy: false positive results caused by radiation necrosis","volume":"40","author":"Liu","year":"1999","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117443_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Svastov\u00e1","year":"2004","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117443_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10555-007-9064-0","article-title":"Regulation of tumor pH and the role of carbonic anhydrase 9","volume":"26","author":"Swietach","year":"2007","journal-title":"Cancer Metast. Rev."},{"issue":"13","key":"10.1016\/j.ejmech.2025.117443_bib16","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1021\/acs.jmedchem.6b00623","article-title":"Synthesis and in vivo biological evaluation of 68Ga-labeled carbonic anhydrase IX targeting small molecules for positron emission tomography","volume":"59","author":"Sneddon","year":"2016","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2025.117443_bib17","doi-asserted-by":"crossref","first-page":"10860","DOI":"10.1021\/acs.jmedchem.8b01504","article-title":"4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced antiproliferative profiles","volume":"61","author":"Nocentini","year":"2018","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117443_bib18","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2217\/fon.15.11","article-title":"Is carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia?","volume":"11","author":"Li","year":"2015","journal-title":"Future Oncol."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117443_bib19","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.2967\/jnumed.114.153288","article-title":"Trimeric radiofluorinated sulfonamide derivatives to achieve in vivo selectivity for carbonic anhydrase IX-targeted PET imaging","volume":"56","author":"Lau","year":"2015","journal-title":"J. Nucl. Med."},{"issue":"21","key":"10.1016\/j.ejmech.2025.117443_bib20","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1021\/jm4009532","article-title":"Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides\/sulfamides\/sulfamates","volume":"56","author":"Rami","year":"2013","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117443_bib21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acs.jmedchem.7b01678","article-title":"Next-generation hypoxic cell radiosensitizers: nitroimidazole alkylsulfonamides","volume":"61","author":"Bonnet","year":"2018","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117443_bib22","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1021\/acs.molpharmaceut.9b00075","article-title":"Synthesis and bioevaluation of novel 18F FDG-conjugated 2-nitroimidazole derivatives for tumor hypoxia imaging","volume":"16","author":"Yang","year":"2019","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117443_bib23","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1134\/S1070428019090197","article-title":"Novel and efficient synthesis of deuterium-labeled olopatadine-d6","volume":"55","author":"Endoori","year":"2019","journal-title":"Russ. J. Org. Chem+"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117443_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1099-1344(199804)41:4<255::AID-JLCR89>3.0.CO;2-O","article-title":"Electrophilic radioiodination of tyrosine derivatives","volume":"41","author":"Farah","year":"1998","journal-title":"J. Label. Compd. Radiopharm."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117443_bib25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0969-8043(94)90230-5","article-title":"Electrophilic radioiodination of tyrosine analogs -their in-vivo stability and brain-uptake in mice","volume":"45","author":"Krummeich","year":"1994","journal-title":"Appl. Radiat. Isot."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117443_bib26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/03602538308991396","article-title":"Plasma and tissue binding considerations in drug disposition","volume":"14","author":"Wilkinson","year":"1983","journal-title":"Durg Metab. Rev."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117443_bib27","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s10967-022-08267-4","article-title":"Synthesis and bioevaluation of radioiodated nitroimidazole-based hypoxia imaging agents containing different charged substituents","volume":"331","author":"Su","year":"2022","journal-title":"J. Radioanal. Nucl. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117443_bib28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1021\/acs.inorgchem.1c02786","article-title":"To be, or not to be, an inhibitor: a comparison of azole interactions with and oxidation by a cytochrome P450 enzyme","volume":"61","author":"Podgorski","year":"2022","journal-title":"Inorg. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117443_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0969-8051(01)00267-0","article-title":"Cellular accumulation and retention of the technetium-99m-labelled hypoxia markers BRU59-21 and butylene amine oxime","volume":"28","author":"Zhang","year":"2001","journal-title":"Nucl. Med. Biol."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117443_bib30","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1021\/acs.jpclett.7b00697","article-title":"Single or multiple access channels to the CYP450s active site? An answer from free energy simulations of the human aromatase enzyme","volume":"8","author":"Magistrato","year":"2017","journal-title":"J. Phys. Chem. Lett."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117443_bib31","first-page":"70","article-title":"F. Research progress on substrates, inhibitors, inducers, and species specificity of CYP450","volume":"12","author":"Liu","year":"2023","journal-title":"Pharm. Inf."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117443_bib32","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1021\/jm3015348","article-title":"Synthesis and SAR of novel Re\/99mTc-labeled benzenesulfonamide carbonic anhydrase IX inhibitors for molecular imaging of tumor hypoxia","volume":"56","author":"Lu","year":"2013","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117443_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.radonc.2007.04.018","article-title":"Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors","volume":"83","author":"Dubois","year":"2007","journal-title":"Radiother. Oncol."},{"issue":"24","key":"10.1016\/j.ejmech.2025.117443_bib34","doi-asserted-by":"crossref","first-page":"15577","DOI":"10.1021\/acs.analchem.9b03600","article-title":"Imaging tumorous methylglyoxal by an activatable near-infrared fluorescent probe for monitoring glyoxalase 1 activity","volume":"91","author":"Ding","year":"2019","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117443_bib35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bmc.2017.12.006","article-title":"Discovery of orally efficacious ROR\u03b3t inverse agonists, part 1: identification of novel phenylglycinamides as lead scaffolds","volume":"26","author":"Shirai","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117443_bib36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jconrel.2021.01.034","article-title":"Oxygen-release microspheres capable of releasing oxygen in response to environmental oxygen level to improve stem cell survival and tissue regeneration in ischemic hindlimbs","volume":"331","author":"Guan","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2025.117443_bib37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejmech.2012.09.042","article-title":"99mTc\/Re complexes bearing bisnitroimidazole or mononitroimidazole as potential bioreductive markers for tumor: synthesis, physicochemical characterization and biological evaluation","volume":"58","author":"Mei","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117443_bib38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.bmcl.2010.10.130","article-title":"Synthesis and biological characterisation of novel dithiocarbamate containing 5-nitroimidazole 99mTc-complexes as potential agents for targeting hypoxia","volume":"21","author":"Giglio","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117443_bib39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.nucmedbio.2015.11.001","article-title":"Kit formulation for preparation and biological evaluation of a novel 99mTc-oxo complex with metronidazole xanthate for imaging tumor hypoxia","volume":"43","author":"Li","year":"2016","journal-title":"Nucl. Med. Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117443_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s007750100291","article-title":"Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships","volume":"7","author":"Dearling","year":"2002","journal-title":"J. Biol. Inorg. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117443_bib41","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1021\/acs.molpharmaceut.8b01120","article-title":"Development of the 99mTc-hydroxamamide complex as a probe targeting carbonic anhydrase IX","volume":"16","author":"Iikuni","year":"2019","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117443_bib42","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1021\/acs.molpharmaceut.8b01210","article-title":"Targeting CAIX with 64Cu XYIMSR-06 small molecular radiotracer enables noninvasive PET imaging of malignant glioma in U87 MG tumor cell xenograft mice","volume":"16","author":"Yang","year":"2019","journal-title":"Mol. Pharm."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:08:28Z","timestamp":1777529308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425002089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":42,"alternative-id":["S0223523425002089"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117443","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and in vitro evaluation of radioiodine labeled hypoxia-targeted drugs containing 2-nitroimidazole and benzenesulfonamide groups","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117443"}}